Angiotensin converting enzyme and sodium glucose cotransporter inhibitors alleviate inflammatory effects of SARS-CoV-2 in cardiomyocytes

Cardiol J. 2022;29(4):702-706. doi: 10.5603/CJ.a2022.0033. Epub 2022 May 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiotensin Receptor Antagonists / pharmacology
  • COVID-19*
  • Humans
  • Myocytes, Cardiac / metabolism
  • Peptidyl-Dipeptidase A / metabolism
  • Peptidyl-Dipeptidase A / pharmacology
  • Renin-Angiotensin System
  • SARS-CoV-2*
  • Sodium-Glucose Transport Proteins / pharmacology

Substances

  • Angiotensin Receptor Antagonists
  • Sodium-Glucose Transport Proteins
  • Peptidyl-Dipeptidase A